Drug Industry
Article Abstract:
Improving fundamentals account for the advance of the drug industry although it has its share of troubled companies like Bristol-Myers Squibb, and Schering-Plough. Rising consumer confidence, weakening dollar and aggressive drug makers are boosting growth through price increases.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Drug industry
Article Abstract:
Large scale investment in biotechnology stocks compared with relatively little movement in the older pharmaceutical companies has been reversed recently. Includes details of related companies.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Drug industry
Article Abstract:
Drug industry stocks should be evaluated individually for investment purposes.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: